ClinicalTrials.gov
public full text
Public Domain
VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
Sildenafil is a selective pulmonary vasodilator; in patients with a special kind of pulmonary hypertension it is approved for treatment. The trial seeks to find out, whether the acute response to this treatment (= vasoreactivity testing) given intravenously is effective and allows prediction of therapy success during a following oral treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- China Pulmonary Vascular Disease Intervention Diagnosis and Management Study-right Heart Catheterization#966615
- Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension#256981
- Phenotype Guided Vasoactive Medication During Kidney Transplantation#828437
- Iloprost for Bridging to Heart Transplantation in PH#893679
- Hemodiafiltration beyond the CONVINCE trial.#251220
Record · ID 1163504
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive